Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Torelli

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Haematologica|March 25, 2014
Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cellsGiovanni F Torelli, Nadia Peragine, Sara Raponi, et al.
Leukemia Research|April 5, 2011
The immune reconstitution after an allogeneic stem cell transplant correlates with the risk of graft-versus-host disease and cytomegalovirus infectionGiovanni F Torelli, Barbarella Lucarelli, Anna P Iori, et al.
British Journal of Haematology|February 4, 2012
Growth factor-associated graft-versus-host disease and mortality 10 years after allogeneic bone marrow transplantationOlle Ringdén, Myriam Labopin, Norbert-Claude Gorin, et al.
Neurology|March 29, 2007
Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosisD Centonze, G Koch, V Versace, et al.
Oncotarget|June 7, 2014
Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemiaValentina Folgiero, Bianca M Goffredo, Perla Filippini, et al.
Blood Transfusion = Trasfusione Del Sangue|March 12, 2015
A good manufacturing practice method to ex vivo expand natural killer cells for clinical useGiovanni F Torelli, Carmela Rozera, Laura Santodonato, et al.
Transplantation|March 7, 2008
B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantationAnna P Iori, Giovanni F Torelli, Maria S De Propris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2011
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphomaP L Zinzani, M Tani, A Pulsoni, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Haematologica|March 25, 2014
Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cellsGiovanni F Torelli, Nadia Peragine, Sara Raponi, et al.
Leukemia Research|April 5, 2011
The immune reconstitution after an allogeneic stem cell transplant correlates with the risk of graft-versus-host disease and cytomegalovirus infectionGiovanni F Torelli, Barbarella Lucarelli, Anna P Iori, et al.
British Journal of Haematology|February 4, 2012
Growth factor-associated graft-versus-host disease and mortality 10 years after allogeneic bone marrow transplantationOlle Ringdén, Myriam Labopin, Norbert-Claude Gorin, et al.
Neurology|March 29, 2007
Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosisD Centonze, G Koch, V Versace, et al.
Oncotarget|June 7, 2014
Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemiaValentina Folgiero, Bianca M Goffredo, Perla Filippini, et al.
Blood Transfusion = Trasfusione Del Sangue|March 12, 2015
A good manufacturing practice method to ex vivo expand natural killer cells for clinical useGiovanni F Torelli, Carmela Rozera, Laura Santodonato, et al.
Transplantation|March 7, 2008
B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantationAnna P Iori, Giovanni F Torelli, Maria S De Propris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2011
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphomaP L Zinzani, M Tani, A Pulsoni, et al.
Pageof 7